Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)
Clinical trial NCT06317051 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06317051
- Sponsor
- Kirby Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2026-07-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.